Sorrento Therapeutics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Sorrento Therapeutics

Access the complete profile.

Sorrento Therapeutics Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	500 - 1,000Exact Company Size
Primary Industry	5411 Legal Services
Additional NAICS Codes	5417 Scientific Research & Development Services 541711 Research & Development in Biotechnology
Address	4955, Directors Place San Diego, CA 92121

Sorrento Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Sorrento Therapeutics's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Sorrento Therapeutics is classified as operating in the Legal Services industry, NAICS Code 5411.

Sorrento Therapeutics is a publicly traded company on NCM using the ticker symbol SRNE. Detailed information on company financials and operating reports can be found here: NCM: SRNE

Sorrento Therapeutics Annual Revenue and Growth Rate

Sorrento Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$100 - $500 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Sorrento Therapeutics's revenues are gauged from an analysis of company filings.

Investor Activity

Sorrento Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
October 22, 2013	9	100%	$2 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Sorrento Therapeutics is developing and marketing. Sorrento Therapeutics doesn't have any recent trademark applications, indicating Sorrento Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
COVIMARK lateral flow viral antigen diagnostic test in the nature of a medical diagnostic test strip for testing bodily fluids for use in detecting COVID-19; Medical diagnostic test kits for the clinical detection of COVID-19 and Coronavirus comprised primarily of lateral flow tests in the nature of test strips for testing body fluids	02/23/2022
FUJOVEE Pharmaceutical preparations for the prevention and treatment of COVID-19 and Coronaviruses, cancer and auto-immune diseases	01/12/2022
AURKEO Pharmaceutical preparations for the prevention and treatment of COVID-19 and Coronaviruses, cancer and auto-immune diseases	01/12/2022

See all trademarks and details in the Full Report.

Market Share of Sorrento Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Sorrento Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
AUSTIN 316 FIDUCIARY LIMITED	Oceanside, NY	100
CONSILIO	Washington, DC	66
LATHAM & WATKINS	Los Angeles, CA	54
KIRKLAND & ELLIS	Chicago, IL	49
CO STATE FRATERNAL ORDER OF POLICE	Westminster, CO	44
GREENBERG TRAURIG P.A.	Miami, FL	42
PROFESSIONAL LAW ENFORCEMENT A	Rochester, MI	38
CHG COMPANIES	Midvale, UT	35
BAKER & MCKENZIE	Chicago, IL	33

Nearby Competitors

These companies are similar in business line and location to Sorrento Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
ROBBINS GELLER RUDMAN & DOWD	San Diego, CA	100
PROCOPIO CORY HARGREAVES & SAVITCH	San Diego, CA	89
MCCARTHY & HOLTHUS	San Diego, CA	63
KIMBALL TIREY & ST. JOHN	San Diego, CA	61
LEGAL AID SOCIETY OF SAN DIEGO	San Diego, CA	53
WAYNE D. THOMAS APC	San Diego, CA	37

Future Competition: Sorrento Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Sorrento Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)